Trinity Biotech PLC
trinitybiotech.comWhat Do They Do?
Develops and sells medical diagnostic tests and instruments to clinical and reference laboratories and public health authorities, while developing wearable biosensors for diabetes management.
20-F for FY2025, filed Apr 30, 2026We are a biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors. Following the…View ↗
We supply the clinical laboratory segment of the in-vitro diagnostic market with a range of diagnostic tests and instrumentation which…View ↗
Many of the products in our infectious diseases product line are FDA cleared for sale in the United States and CE marked in Europe.…View ↗
In January 2024, we acquired the biosensor and CGM assets of privately held Waveform Technologies, Inc. (“Waveform”). We are currently…View ↗
Who Are Their Customers?
Clinical and reference laboratories, hospitals, and public health authorities buy diagnostic products and testing services. Trinity sells directly in the United States and Brazil, and directly to hospitals and laboratories in Germany and France for clinical chemistry; distributors and strategic partners serve other markets.
20-F for FY2025, filed Apr 30, 2026Many of the products in our infectious diseases product line are FDA cleared for sale in the United States and CE marked in Europe.…View ↗
The diagnostic product line is complemented by Immco’s New York State Department of Health licenced reference laboratory offering…View ↗
We sell our products through our own direct sales force in the United States Our sales team in the United States is responsible for…View ↗
our clinical chemistry product range directly to hospitals and laboratories in Germany and France; andView ↗
all product lines through independent distributors and strategic partners in a further approximately 100 countries, with product…View ↗
How Are They Changing?
Wearable biosensors
The older report describes diagnostic products, while the latest also describes wearable biosensors for diabetes management, developed after acquiring Waveform’s biosensor assets.
20-F for FY2022, filed May 16, 2023 20-F for FY2025, filed Apr 30, 2026We and our subsidiaries (the “Group”) develop, acquire, manufacture and market medical diagnostic products for the clinical laboratory and…View ↗
Who Do They Compete With?
Competes with Abbott, Arkray, Becton Dickenson, Bio-Rad, Copan, Dexcom, Diasorin, Johnson & Johnson, Roche, Sebia, Siemens, Thermo Fisher, Tosoh, and Werfen
20-F for FY2025, filed Apr 30, 2026The Group’s competition includes several large companies such as, but not limited to: Abbott Diagnostics, Arkray, Becton Dickenson…View ↗
Loading...
